Scientific Advisors to Stem Cell Agency: Time to Move 'At Speed'
John Bell, chair of CIRM SAB
Academy of Medical Sciences photo
The $3 billion California stem cell agency is preparing to take a close look at recommendations from key advisors that it should focus more sharply on a handful projects in order to transform research rapidly into commercial therapies.
The governing board's Science Subcommittee on Nov. 22 will …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.